Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
816.10
+8.43 (1.04%)
At close: Oct 27, 2026, 4:00 PM EDT
815.75
-0.35 (-0.04%)
Pre-market: Oct 28, 2026, 5:26 AM EDT
Regeneron Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $960 → $980 | Buy | Maintains | $960 → $980 | +20.08% | Oct 21, 2026 |
| Leerink Partners | Leerink Partners | Hold Maintains $824 → $835 | Hold | Maintains | $824 → $835 | +2.32% | Oct 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $854 → $865 | Buy | Maintains | $854 → $865 | +5.99% | Oct 19, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $750 | Hold | Maintains | $750 | -8.10% | Oct 15, 2026 |
| UBS | UBS | Buy Initiates $660 → $978 | Buy | Initiates | $660 → $978 | +19.84% | Oct 14, 2026 |
| Scotiabank | Scotiabank | Hold Maintains $770 | Hold | Maintains | $770 | -5.65% | Oct 14, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $920 | Buy | Maintains | $920 | +12.73% | Oct 12, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $891 → $908 | Buy | Reiterates | $891 → $908 | +11.26% | Oct 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.